LED Therapy and Indian Skin Tones: What the Research Actually Says About Melanin and Hyperpigmentation

Indian skin produces more eumelanin, the dense, photoprotective pigment that sits in the epidermis and absorbs incoming light across a wide spectrum. That melanin is the reason Indian skin tans instead of burning, resists UV damage longer, and ages more slowly than Fitzpatrick I-II skin. It is also the reason LED therapy does not behave identically on brown skin as it does on the pale skin that dominated early photobiomodulation research.

The core issue is competitive absorption. When red or near-infrared light enters the skin, melanin and the target chromophores, cytochrome c oxidase in mitochondria, haemoglobin in blood vessels, compete for photons. Higher melanin density means more photons are absorbed before they reach the dermis. A 2021 review published in the Journal of Biophotonics noted that penetration depth of 630 to 660 nm red light is measurably reduced in Fitzpatrick V-VI skin, requiring either higher fluence or longer exposure to achieve comparable dermal effects. This does not make LED therapy ineffective on Indian skin. It makes the dosing question more important than device manufacturers typically acknowledge.

Red light, typically 630 to 670 nm, stimulates fibroblast activity and collagen synthesis. A 2014 randomised controlled trial by Wunsch and Matuschka, published in Photomedicine and Laser Surgery, found statistically significant improvements in skin complexion and collagen density after 30 twice-weekly sessions. The trial used Fitzpatrick I-IV participants. The collagen benefit is real, but the sample skews lighter than the average Indian complexion.

For Indian skin specifically, the more clinically relevant application of red light is post-inflammatory hyperpigmentation, the dark marks that follow acne, rashes, or any skin trauma. PIH is disproportionately common in Fitzpatrick III-VI skin because melanocytes in darker skin are larger, more reactive, and produce pigment more aggressively in response to inflammation. Red light's anti-inflammatory action can interrupt this cycle at the source. A 2019 study in the Journal of Clinical and Aesthetic Dermatology found red LED therapy reduced inflammatory acne lesions by 36% over eight weeks, with secondary reductions in post-acne pigmentation. The PIH reduction was more pronounced in participants with darker skin tones, which the authors attributed to a higher baseline inflammatory burden in those participants.

Blue light at 415 nm is the most evidence-backed LED wavelength for acne. It targets Cutibacterium acnes bacteria directly, activating endogenous porphyrins inside the bacteria that produce singlet oxygen and destroy the cell. A Cochrane review of phototherapy for acne confirmed blue light as effective for mild-to-moderate inflammatory acne.

The complication for Indian skin is that blue light is also absorbed heavily by melanin. At 415 nm, epidermal melanin absorption is at its highest across the visible spectrum. Two things follow from this. First, blue light penetrates less deeply into Indian skin, which may reduce its antibacterial effect in deeper follicles. Second, repeated blue light exposure can stimulate melanogenesis, the production of new melanin, in susceptible individuals, potentially worsening hyperpigmentation rather than clearing it. Dermatologists at AIIMS New Delhi have flagged this in clinical guidance for South Asian patients: blue LED devices should be used at lower fluence settings and not on already-pigmented lesions.

The practical takeaway is not to avoid blue light entirely but to use it in short, spaced sessions and monitor for darkening at treated sites.

Near-infrared light, at 830 to 850 nm, penetrates deeper than red or blue and is absorbed less by melanin. At these wavelengths, the competitive absorption problem diminishes significantly. Near-infrared stimulates mitochondrial activity, reduces oxidative stress, and has shown promise in wound healing and scar remodelling, both relevant concerns for Indian skin, where keloid and hypertrophic scarring rates are higher than in lighter skin types.

A 2020 study in Lasers in Medical Science tested 830 nm LED therapy on post-surgical scars in participants with Fitzpatrick IV-V skin and found significant reductions in scar thickness and pigmentation over 12 weeks. The melanin advantage here is real: because near-infrared bypasses the eumelanin absorption peak, Indian skin gets more of the photons where it matters, in the dermis and subcutaneous tissue, rather than losing them in the epidermis.

LED therapy devices sold in India range from clinical-grade panels used by dermatologists to handheld consumer devices with unverified output specifications. The gap matters. Clinical devices specify irradiance in mW/cm² and have been tested for wavelength accuracy. Consumer devices frequently do not, and several tested by independent reviewers have been found to emit wavelengths outside their stated range by 20 to 40 nm, enough to shift from therapeutic to sub-therapeutic or to a different chromophore target entirely.

Before a session, ask the clinic three things: the exact wavelength being used, the irradiance setting, and whether the protocol has been adjusted for your Fitzpatrick type. A clinic that cannot answer the first two questions is working from a sales pitch, not a protocol. For at-home devices, prioritise near-infrared over blue if your primary concern is hyperpigmentation or collagen, since near-infrared's reduced melanin absorption makes it the most forgiving wavelength for Indian skin across the Fitzpatrick range.

The research on LED therapy is real, but it was built on skin that does not look like most Indian faces. The wavelengths that work best for darker skin are not always the ones being marketed most aggressively, and the skin that stands to gain the most from getting the protocol right is exactly the skin that has been studied the least.